Short-acting β-agonist use and its ability to predict future asthma-related outcomes.
CONCLUSION: The study identified critical values of SABA use that predict future asthma events. Each additional SABA canister predicted increases in exacerbation risk in children and adults.
PMID: 23176877 [PubMed - in process]
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Stanford RH, Shah MB, D'Souza AO, Dhamane AD, Schatz M Tags: Ann Allergy Asthma Immunol Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Children | Databases & Libraries | Insurance | Medicaid | Pediatrics | Study